IL-6-induced FOXO1 activity determines the dynamics of metabolism in CD8 T cells cross-primed by liver sinusoidal endothelial cells.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
15 02 2022
Historique:
received: 03 05 2021
revised: 16 11 2021
accepted: 25 01 2022
entrez: 16 2 2022
pubmed: 17 2 2022
medline: 3 3 2022
Statut: ppublish

Résumé

Liver sinusoidal endothelial cells (LSECs) are liver-resident antigen (cross)-presenting cells that generate memory CD8 T cells, but metabolic properties of LSECs and LSEC-primed CD8 T cells remain understudied. Here, we report that high-level mitochondrial respiration and constitutive low-level glycolysis support LSEC scavenger and sentinel functions. LSECs fail to increase glycolysis and co-stimulation after TLR4 activation, indicating absence of metabolic and functional maturation compared with immunogenic dendritic cells. LSEC-primed CD8 T cells show a transient burst of oxidative phosphorylation and glycolysis. Mechanistically, co-stimulatory IL-6 signaling ensures high FOXO1 expression in LSEC-primed CD8 T cells, curtails metabolic activity associated with T cell activation, and is indispensable for T cell functionality after re-activation. Thus, distinct immunometabolic features characterize non-immunogenic LSECs compared with immunogenic dendritic cells and LSEC-primed CD8 T cells with memory features compared with effector CD8 T cells. This reveals local features of metabolism and function of T cells in the liver.

Identifiants

pubmed: 35172161
pii: S2211-1247(22)00110-3
doi: 10.1016/j.celrep.2022.110389
pii:
doi:

Substances chimiques

Forkhead Box Protein O1 0
Foxo1 protein, mouse 0
Interleukin-6 0
Toll-Like Receptor 4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110389

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Michael Dudek (M)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany.

Kerstin Lohr (K)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany.

Sainitin Donakonda (S)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany.

Tobias Baumann (T)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany.

Max Lüdemann (M)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany.

Silke Hegenbarth (S)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany.

Lena Dübbel (L)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany.

Carola Eberhagen (C)

Institute of Toxicology, Helmholtz Center München, München, Germany.

Savvoula Michailidou (S)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany.

Abdallah Yassin (A)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany.

Marco Prinz (M)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany; Center for NeuroModulation, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg im Breisgau, Germany.

Bastian Popper (B)

Biomedical Center, Ludwig-Maximilians-University Munich, München, Germany.

Stefan Rose-John (S)

Institute of Biochemistry, University of Kiel, Kiel, Germany.

Hans Zischka (H)

Institute of Toxicology, Helmholtz Center München, München, Germany; Institute of Toxicology and Environmental Hygiene, Technical University Munich, München, Germany.

Percy A Knolle (PA)

Institute of Molecular Immunology and Experimental Oncology, University Hospital München rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675 München Germany; German Center for Infection Research, Munich site, München, Germany. Electronic address: percy.knolle@tum.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH